UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies

Clinical cancer research, 2010-02, Vol.16 (4), p.1256-1263

2010

Volltextzugriff (PDF)

PRL-3 Expression in Metastatic Cancers

Clinical cancer research, 2003-11, Vol.9 (15), p.5607-5615

2003

Volltextzugriff (PDF)

Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers

Science (American Association for the Advancement of Science), 2004-05, Vol.304 (5674), p.1164-1166

2004

Volltextzugriff (PDF)

Concert Series: "Reformation Intersections," Kitchener, Ontario

The Sixteenth century journal, 2017-12, Vol.48 (4), p.1004-1004

Sager, Jason

2017

Volltextzugriff (PDF)

PRL-3: A phosphatase for metastasis?

Cancer biology & therapy, 2004-10, Vol.3 (10), p.952-953

2004

Volltextzugriff (PDF)

Will targeted therapy hold its promise? An evidence-based review

Current opinion in oncology, 2008-01, Vol.20 (1), p.104-111

2008

Volltextzugriff (PDF)

The Mortgage of the Past: Reshaping the Political Inheritance (1050–1300). By Francis Oakley. New Haven, Conn.: Yale University Press, 2012. xvi + 328 pp. $55.00 cloth

Church history, 2013-09, Vol.82 (3), p.704-706

Sager, Jason

2013

Volltextzugriff (PDF)

"GOD REIGNING THROUGH YOU, REIGNS WITH YOU": THE CHARENTON CONTROVERSY AND THE DEVELOPMENT OF ROYAL AUTHORITY IN EARLY BOURBON FRANCE

The Catholic historical review, 2012-07, Vol.98 (3), p.456-475

Sager, Jason

2012

Volltextzugriff (PDF)

Streptomyces bikiniensis bacteremia

Emerging infectious diseases, 2003-02, Vol.9 (2), p.273-274

2003

Volltextzugriff (PDF)

"GOD REIGNINGTHROUGH YOU, REIGNS WITH YOU": THE CHARENTON CONTROVERSY AND THE DEVELOPMENT OF ROYAL AUTHORITY IN EARLY BOURBON FRANCE

The Catholic historical review, 2012-07, Vol.98 (3), p.456

Sager, Jason

2012

Volltextzugriff (PDF)

New Paradigms for Cancer Drug Discovery?

Cancer biology & therapy, 2003-07, Vol.2 (4), p.452-455

2003

Volltextzugriff (PDF)

New paradigms for cancer drug discovery

Cancer biology & therapy, 2003-07, Vol.2 (4 Suppl 1), p.S178-S181

2003

Volltextzugriff (PDF)

Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine–resistant cancer cells

Molecular cancer therapeutics, 2005-06, Vol.4 (6), p.1026-1030

2005

Volltextzugriff (PDF)

Herculean Labours: Erasmus and the Editing of St. Jerome's Letters in the Renaissance. By Hilmar M. Pabel. Library of the Written Word 5. The Handpress World 3. Leiden: Brill, 2008. xvii+389 pp. $148.00 cloth

Church history, 2010-03, Vol.79 (1), p.204-206

Sager, Jason

2010

Volltextzugriff (PDF)

André Thevet. Portraits from the French Renaissance and the Wars of Religion. Early Modern Studies 3. Ed. Roger Schlesinger. Trans. Edward Benson. Kirksville: Truman State University Press, 2010. xxxiv + 201 pp. index. illus. map. chron. bibl. $39.95.. ISBN: 978–1–931112–98–7

Renaissance quarterly, 2010, Vol.63 (3), p.923-924

Sager, Jason

2010

Volltextzugriff (PDF)

Abstract 520: circBRIP1 RNA as a non-invasive target engagement pharmacodynamic biomarker for DHX9 inhibition

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.520-520

2024

Volltextzugriff (PDF)

Abstract 3908: DHX9 inhibition as a novel therapeutic for cancer with loss-of-function mutations in DNA damage repair genes BRCA1 and BRCA2

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.3908-3908

2024

Volltextzugriff (PDF)

Abstract PR003: DHX9 inhibition as a novel therapeutic for ovarian and breast cancer with loss-of-function mutations in the DNA damage repair genes BRCA1 or BRCA2

Cancer research (Chicago, Ill.), 2024-01, Vol.84 (1_Supplement), p.PR003-PR003

2024

Volltextzugriff (PDF)

Abstract SY11-02: Small molecule inhibitors of RNA modifying enzymes as precision cancer therapeutics

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.SY11-02-SY11-02

2024

Volltextzugriff (PDF)

For the Good or the “Guild”: Responses to Kate Daley-Bailey’s Open Letter to the American Academy of Religion

Bulletin for the study of religion, 2017-04, Vol.46 (1), p.24-38

2017

Volltextzugriff (PDF)

Abstract 2201: The molecular signature of tumor cells that are sensitives to a new tight binder NAMPT inhibitor

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2201-2201

2013

Volltextzugriff (PDF)

Abstract 4731: Cytotoxic versus cytostatic effects in tumor models by spiro-oxindole-based modulators of the MDM2-p53 interaction

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4731-4731

2012

Volltextzugriff (PDF)

Discodermolide analogues as the chemical component of combination bacteriolytic therapy

Bioorganic & medicinal chemistry letters, 2005-08, Vol.15 (15), p.3623-3626

2005

Volltextzugriff (PDF)

Abstract 2775: A phase I study of LCL161, an oral IAP inhibitor, in patients with advanced cancer

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.2775-2775

2010

Volltextzugriff (PDF)

New Paradigms for Cancer Drug Discovery?

Cancer biology & therapy, 2003-03, Vol.2 (sup1), p.177-180

2003

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(89)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(99)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(30)
Humans
(29)
History
(17)
Arts & Humanities
(14)
Male
(13)
Nonfiction
(12)
Female
(11)
Animals
(10)
Biological And Medical Sciences
(9)
Medical Sciences
(7)
Middle Aged
(7)
Oncology
(7)
Adult
(6)
Ophthalmology
(6)
Physical Sciences
(6)
Aged
(5)
Antineoplastic Agents - Pharmacology
(5)
Biology
(5)
Cancer
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies

PRL-3 Expression in Metastatic Cancers

Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers

Concert Series: "Reformation Intersections," Kitchener, Ontario

PRL-3: A phosphatase for metastasis?

Will targeted therapy hold its promise? An evidence-based review

The Mortgage of the Past: Reshaping the Political Inheritance (1050–1300). By Francis Oakley. New Haven, Conn.: Yale University Press, 2012. xvi + 328 pp. $55.00 cloth

"GOD REIGNING THROUGH YOU, REIGNS WITH YOU": THE CHARENTON CONTROVERSY AND THE DEVELOPMENT OF ROYAL AUTHORITY IN EARLY BOURBON FRANCE

Streptomyces bikiniensis bacteremia

"GOD REIGNINGTHROUGH YOU, REIGNS WITH YOU": THE CHARENTON CONTROVERSY AND THE DEVELOPMENT OF ROYAL AUTHORITY IN EARLY BOURBON FRANCE

New Paradigms for Cancer Drug Discovery?

New paradigms for cancer drug discovery

Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine–resistant cancer cells

Herculean Labours: Erasmus and the Editing of St. Jerome's Letters in the Renaissance. By Hilmar M. Pabel. Library of the Written Word 5. The Handpress World 3. Leiden: Brill, 2008. xvii+389 pp. $148.00 cloth

André Thevet. Portraits from the French Renaissance and the Wars of Religion. Early Modern Studies 3. Ed. Roger Schlesinger. Trans. Edward Benson. Kirksville: Truman State University Press, 2010. xxxiv + 201 pp. index. illus. map. chron. bibl. $39.95.. ISBN: 978–1–931112–98–7

Abstract 520: circBRIP1 RNA as a non-invasive target engagement pharmacodynamic biomarker for DHX9 inhibition

Abstract 3908: DHX9 inhibition as a novel therapeutic for cancer with loss-of-function mutations in DNA damage repair genes BRCA1 and BRCA2

Abstract PR003: DHX9 inhibition as a novel therapeutic for ovarian and breast cancer with loss-of-function mutations in the DNA damage repair genes BRCA1 or BRCA2

Abstract SY11-02: Small molecule inhibitors of RNA modifying enzymes as precision cancer therapeutics

For the Good or the “Guild”: Responses to Kate Daley-Bailey’s Open Letter to the American Academy of Religion

Abstract 2201: The molecular signature of tumor cells that are sensitives to a new tight binder NAMPT inhibitor

Abstract 4731: Cytotoxic versus cytostatic effects in tumor models by spiro-oxindole-based modulators of the MDM2-p53 interaction

Discodermolide analogues as the chemical component of combination bacteriolytic therapy

Abstract 2775: A phase I study of LCL161, an oral IAP inhibitor, in patients with advanced cancer

New Paradigms for Cancer Drug Discovery?

Suchergebnisse filtern